DLEU1 and glioblastoma: Considering the critical role of XTP6 in maintaining the activation of the NF-κB signaling pathway for GBM progression, we proceeded to investigate whether inhibiting NF-κB signaling pathway could prevent the XTP6-driven GBM progression through constructing in vivo model (Fig. 7A).